BioSpace News Archive

Bristol-Myers Squibb Company announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended the expanded approval of Sprycel (dasatinib), in combination with chemotherapy, to include the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).

Carevide Dental, a nonprofit organization with more than 40 years of experience in providing health care services, has five medical, dental, pediatrics and women’s health sites serving five counties in Northeast Texas.

Pharmacists United for Truth and Transparency (PUTT) and the Pharmacists Society of the State of New York (PSSNY) have jointly filed a motion asking U.S. District Court Richard Leon to stop CVS and Aetna from further integration while the Court determines the merger’s potentially harmful effect on consumers and smaller competitors.

Cloud Practice offers cloud-based electronic medical records software applications for physicians throughout Canada

If approved, Biogen intends to market diroximel fumarate under the brand name VUMERITY™.

Effective January 2, 2019.

The grants represent a joint effort to promote and support innovative research on Tumor Treating Fields.

10 programs selected to help support healthcare capacity building in resource-constrained countries

Southern Regenerative Health, the aesthetic division of RBC Medical Services, is now offering state-of-the-art laser tattoo removal treatment for patients throughout Gulfport, Biloxi, Diamondhead, and other surrounding cities in Mississippi.

Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, and Planet Innovation, a healthtech innovation and commercialization company, are pleased to announce that they have entered into a Master Service Agreement